Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma

NCT00299182 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: AMG 531
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]